COSMOS Pharmaceutical CorporationJP:3349

Market cap
¥684,814m
P/E ratio
28.5
SummaryIncome statementBalance sheetCash flow
May 31,
2010		May 31,
2011		May 31,
2012		May 31,
2013		May 31,
2014		May 31,
2015		May 31,
2016		May 31,
2017		May 31,
2018		May 31,
2019		May 31,
2020		May 31,
2021		May 31,
2022		May 31,
2023
Net sales205,387237,174279,021329,313371,825408,466447,273502,732557,999611,137684,403726,424755,414827,697
Ordinary profit (loss)8,80211,07114,51716,78718,19319,02820,69124,59125,25527,29231,56235,83532,86133,086
Profit (loss) attributable to owners of parent
Comprehensive income
Basic earnings (loss) per share
Net cash provided by (used in) operating activities
Net cash provided by (used in) investing activities
Net cash provided by (used in) financing activities